LC
GILD icon

LCNB Corp’s Gilead Sciences GILD Stock Holding History

LCNB Corp’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,294
Closed -$214K – 141
2019
Q4 		$214K Sell
3,294
-30
-0.9% -$1.95K 0.13% 140
2019
Q3 		$211K Sell
3,324
-442
-12% -$28.9K 0.14% 142
2019
Q2 		$254K Sell
3,766
-100
-3% -$6.58K 0.18% 121
2019
Q1 		$251K Sell
3,866
-70
-2% -$4.65K 0.18% 121
2018
Q4 		$246K Sell
3,936
-175
-4% -$12.2K 0.2% 112
2018
Q3 		$317K Sell
4,111
-270
-6% -$20.4K 0.22% 105
2018
Q2 		$310K Buy
+4,381
New +$309K 0.28% 83

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

LCNB Corp's GILD Position: Q1 2020 in Review

LCNB Corp sold out of Gilead Sciences (GILD) in Q1 2020, closing a stake of 3,294 shares — an estimated $214K sold.

LCNB Corp first reported a position in GILD in Q2 2018 and held it in 7 quarters. The position peaked at $317K in Q3 2018. 1,643 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

  • LCNB Corp reported no remaining Gilead Sciences position as of Q1 2020 after selling out during the quarter.
  • LCNB Corp sold 3,294 Gilead Sciences shares in Q1 2020, an estimated $214K.
  • LCNB Corp first reported a position in Gilead Sciences in Q2 2018 and held it in 7 quarters.
  • LCNB Corp's Gilead Sciences position peaked at $317K in Q3 2018.
  • 1,643 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on LCNB Corp's 13F filing for Q1 2020, filed 11 May 2020.